Sourcebio International Plc (LON:SBI – Get Free Report) shares traded up 4.5% on Thursday . The stock traded as high as GBX 125 ($1.56) and last traded at GBX 115 ($1.43). 1,571,282 shares changed hands during mid-day trading, an increase of 931% from the average session volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.37).
Sourcebio International Stock Up 4.5 %
The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 35.10. The company has a market capitalization of £85.31 million and a P/E ratio of 1,277.78. The firm has a 50-day moving average price of GBX 115 and a two-hundred day moving average price of GBX 115.
About Sourcebio International
Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.
Featured Articles
- Five stocks we like better than Sourcebio International
- What Does Downgrade Mean in Investing?
- Comprehensive PepsiCo Stock Analysis
- Why Invest in 5G? How to Invest in 5G Stocks
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Sourcebio International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sourcebio International and related companies with MarketBeat.com's FREE daily email newsletter.